Financials
- Market Capitalization 173.68 M
- Employee 97
- Founded 2011
- CEO N/A
- Website www.cariboubio.com
- Headquarter Delaware, United States
- FIGI BBG008G28LJ5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3697 | ADAG Adagene Inc - ADS, each representing 1.25 | 3.68 USD | -5.64% | -7.77% | -2.65% | +73.58% | 174.38 M USD | ||
| 3699 | CDXS Codexis, Inc. - Common Stock | 1.59 USD | -4.22% | -5.36% | +7.43% | -41.11% | 174.11 M USD | ||
| 3706 | QSI Quantum-Si Incorporated - Class A Common Stock | 0.78 USD | -2.50% | -2.50% | +6.85% | -29.09% | 170.73 M USD | ||
| 3720 | MDWD MediWound Ltd. - Ordinary Shares | 12.66 USD | -4.38% | -4.02% | -13.11% | -31.72% | 162.49 M USD |
Frequently asked questions about Caribou Biosciences, Inc. Common Stock
What is the Caribou Biosciences, Inc. Common Stock stock price today?
The current price of Caribou Biosciences, Inc. Common Stock (CRBU) is 1.62. Over the past 24 hours, the stock has changed by -2.41%. Follow the CRBU chart for real-time price dynamics.
What is the stock ticker of Caribou Biosciences, Inc. Common Stock?
Caribou Biosciences, Inc. Common Stock trades under the ticker CRBU. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Caribou Biosciences, Inc. Common Stock stock going up?
CRBU has changed by -3.57% over the last week, +5.88% over the last month, and -12.90% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Caribou Biosciences, Inc. Common Stock?
Caribou Biosciences, Inc. Common Stock currently has a market capitalization of 173.68 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Caribou Biosciences, Inc. Common Stock earnings last quarter?
Last quarter, Caribou Biosciences, Inc. Common Stock reported earnings of -0.24 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Caribou Biosciences, Inc. Common Stock revenue for the last quarter?
Caribou Biosciences, Inc. Common Stock reported quarterly revenue of 1.5 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Caribou Biosciences, Inc. Common Stock net income for the last quarter?
Caribou Biosciences, Inc. Common Stock reported net income of -24.28 M for the last quarter. The previous quarter showed -25.09 M, which means net income changed by +3.20%.
How many employees does Caribou Biosciences, Inc. Common Stock have?
As of the latest available data, Caribou Biosciences, Inc. Common Stock has 97 employees. Workforce size can provide additional context about the company's scale and operations.
What is Caribou Biosciences, Inc. Common Stock EBITDA?
Caribou Biosciences, Inc. Common Stock EBITDA is -24.71 M, and its EBITDA margin is -1 648.7%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Caribou Biosciences, Inc. Common Stock stock?
You can buy Caribou Biosciences, Inc. Common Stock (CRBU) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Caribou Biosciences, Inc. Common Stock stock?
Investing in Caribou Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRBU chart and related analysis on metatrader.com as part of your research.